Civik Thomas Insider Trades

Insider Trading History

Track insider trading activity for Civik Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pyxis Oncology
Pyxis Oncology PYXS
Interim CEO
Holding Value $1.17M 690,131 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 690,131 shares
$1.49
$1.70
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $0 0 shares
Last Trade
Jan 28, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$19.9k 7,500 shares
$2.65
$2.65
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $62.9k 36,979 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2k 36,979 shares
$0.98
$1.70
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $72.1k 27,200 shares
Last Trade
Jun 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103k 27,200 shares
$3.80
$2.65
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $74.8k 44,024 shares
Last Trade
Mar 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 44,024 shares
$3.83
$1.70
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $72.1k 27,200 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$317k 27,200 shares
$11.66
$2.65
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $351k 206,186 shares
Last Trade
Mar 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$308k 139,355 shares
$2.21
$1.70
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $130k 49,000 shares
Last Trade
May 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 49,000 shares
$8.76
$2.65
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $114k 66,831 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 66,831 shares
$4.04
$1.70
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $26.7k 15,700 shares
Last Trade
Nov 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$200k 15,700 shares
$12.74
$1.70
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $19.9k 7,500 shares
Last Trade
Nov 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$211k 7,500 shares
$28.08
$2.65
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2021 Sale
No data
No data
$1.70
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $71.7k 42,191 shares
Last Trade
Oct 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.70
Repare Therapeutics
Repare Therapeutics RPTX
Director
Holding Value $111k 42,000 shares
Last Trade
Sep 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.42M 42,000 shares
$33.89
$2.65
Five Prime Therapeutics
Five Prime Therapeutics FPRX
President And CEO
Holding Value $0 0 shares
Last Trade
Apr 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.62M 68,971 shares
$38.00
$38.00
Five Prime Therapeutics
Five Prime Therapeutics FPRX
President And CEO
Holding Value $2.62M 68,971 shares
Last Trade
Apr 09, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$421k 11,088 shares
$37.94
$38.00
Five Prime Therapeutics
Five Prime Therapeutics FPRX
President And CEO
Holding Value $18.2M 480,000 shares
Last Trade
Apr 13, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 480,000 shares
$2.72
$38.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up